Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

648
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
648
Cancer Survival Analysis01:21

Cancer Survival Analysis

630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

291
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
291
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

653
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
653
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Review of Regenerative Medicine Therapies for Spine-Related Pain.

Current pain and headache reports·2023
Same author

Post-thoracotomy Pain Syndrome.

Current pain and headache reports·2022
Same author

Correction to: Small Fiber Neuropathy.

Current pain and headache reports·2022
Same author

Measurements of tt spin correlations and top-quark polarization using dilepton final states in pp collisions at sqrt[s]=7  TeV.

Physical review letters·2014
Same author

Search for top-quark partners with charge 5/3 in the same-sign dilepton final state.

Physical review letters·2014
Same author

Search for flavor-changing neutral currents in top-quark decays t → Zq in pp collisions at sqrt[s] = 8 TeV.

Physical review letters·2014

Related Experiment Video

Updated: Jan 10, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

9.7K

Chronic Pain in the Cancer Survivor.

Jillian Maloney1, M Kraus2, N Strand3

  • 1Division of Pain Medicine, Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, AZ, USA. Maloney.jillian@mayo.edu.

Current Pain and Headache Reports
|November 27, 2025
PubMed
Summary

Managing chronic pain in cancer survivors is crucial. Duloxetine shows promise for chemotherapy-induced peripheral neuropathy, while other pain types benefit from multimodal therapies including physical therapy and injections.

Keywords:
Cancer survivorChemotherapy-induced peripheral neuropathyChronic pain

More Related Videos

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.6K
Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
02:41

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding

Published on: May 3, 2024

2.1K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
07:14

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery

Published on: January 18, 2018

9.7K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.6K
Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
02:41

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding

Published on: May 3, 2024

2.1K

Area of Science:

  • Oncology
  • Pain Management
  • Survivorship Care

Background:

  • Cancer survivorship is increasing, highlighting the need to address long-term treatment side effects.
  • Chronic pain syndromes are common sequelae of cancer treatments like chemotherapy, radiation, and surgery, impacting quality of life.

Purpose of the Study:

  • To review current evidence and therapeutic strategies for prevalent pain conditions in cancer survivors.
  • To focus on chemotherapy-induced peripheral neuropathy, post-radiation pain, and post-surgical pain syndromes.
  • To guide clinicians in optimizing survivorship care through understanding pathophysiology, diagnostics, and management.

Main Methods:

  • Systematic review of current evidence on cancer-related pain syndromes.
  • Synthesis of data on pathophysiology, diagnostic considerations, and emerging management strategies.
  • Evaluation of therapeutic approaches for chemotherapy-induced peripheral neuropathy, post-radiation pain, and post-surgical pain.

Main Results:

  • Duloxetine is supported by evidence for chemotherapy-induced peripheral neuropathy.
  • Limited efficacy data exists for gabapentinoids and tricyclic antidepressants in chemotherapy-induced peripheral neuropathy.
  • Post-radiation and post-surgical pain syndromes benefit from a multimodal approach including physical therapy, injections, and pharmacologic agents.

Conclusions:

  • A personalized and multimodal approach is recommended for managing chronic pain in cancer survivors.
  • Further research is critical to improve long-term outcomes and quality of life for cancer survivors.
  • Optimizing survivorship care requires effective management of treatment-related chronic pain.